UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.2961-2970

2019

Volltextzugriff (PDF)

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

The lancet. Diabetes & endocrinology, 2017-12, Vol.5 (12), p.941-950

2017

Volltextzugriff (PDF)

Cognition After Lowering LDL-Cholesterol With Evolocumab

Journal of the American College of Cardiology, 2020-05, Vol.75 (18), p.2283-2293

2020

Volltextzugriff (PDF)

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

Scientific reports, 2020-12, Vol.10 (1), p.21655-21655, Article 21655

2020

Volltextzugriff (PDF)

Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation

Heart rhythm, 2013-09, Vol.10 (9), p.1311-1317

2013

Volltextzugriff (PDF)

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

BMJ open, 2019-04, Vol.9 (4), p.e025580-e025580

2019

Volltextzugriff (PDF)

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

Journal of the American College of Cardiology, 2014-02, Vol.63 (4), p.345-354

2014

Volltextzugriff (PDF)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Scientific reports, 2021-09, Vol.11 (1), p.18708-18708, Article 18708

2021

Volltextzugriff (PDF)

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

PLoS medicine, 2009-09, Vol.6 (9), p.e1000154

2009

Volltextzugriff (PDF)

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

International journal of cardiology, 2015-12, Vol.201, p.499-507

2015

Volltextzugriff (PDF)

The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study

PloS one, 2014-04, Vol.9 (4), p.e93980-e93980

2014

Volltextzugriff (PDF)

Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis

PLoS medicine, 2005-03, Vol.2 (3), p.e76-e76

2005

Volltextzugriff (PDF)

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial

Cardiovascular diabetology, 2011-11, Vol.10 (1), p.102-102

2011

Volltextzugriff (PDF)

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Trials, 2019-06, Vol.20 (1), p.366-366, Article 366

2019

Volltextzugriff (PDF)

Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy

Atherosclerosis, 2015-09, Vol.242 (1), p.295-302

2015

Volltextzugriff (PDF)

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Metabolism, clinical and experimental, 2016-05, Vol.65 (5), p.783-793

2016

Volltextzugriff (PDF)

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2190-2197

2008

Volltextzugriff (PDF)

Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study

Journal of the American Heart Association, 2013-12, Vol.2 (5), p.e000360-e000360

2013

Volltextzugriff (PDF)

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

International journal of cardiology, 2013-10, Vol.168 (6), p.5378-5384

2013

Volltextzugriff (PDF)

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Diabetes research and clinical practice, 2014-11, Vol.106 (2), p.328-336

2014

Volltextzugriff (PDF)

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

The lancet. Diabetes & endocrinology, 2021-01, Vol.9 (1), p.32-45

2021

Volltextzugriff (PDF)

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

The lancet. Diabetes & endocrinology, 2016-10, Vol.4 (10), p.829-839

2016

Volltextzugriff (PDF)

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

PLoS medicine, 2005-04, Vol.2 (4), p.e80-e80, Article e80

2005

Volltextzugriff (PDF)

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The lancet. Diabetes & endocrinology, 2024-05, Vol.12 (5), p.306-319

2024

Volltextzugriff (PDF)

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

Diabetes technology & therapeutics, 2023-02, Vol.25 (2), p.108-115

2023

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Science & Technology
(30)
Life Sciences & Biomedicine
(27)
Male
(27)
Middle Aged
(26)
Female
(23)
Double-Blind Method
(12)
Cardiovascular System & Cardiology
(11)
Cardiac & Cardiovascular Systems
(10)
Risk Factors
(10)
Adult
(9)
Cardiovascular Disease
(9)
Endocrinology & Metabolism
(9)
Diabetes
(8)
Diabetes Mellitus, Type 2 - Drug Therapy
(8)
Fenofibrate - Therapeutic Use
(7)
Hypolipidemic Agents - Therapeutic Use
(7)
Treatment Outcome
(7)
Prospective Studies
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

Cognition After Lowering LDL-Cholesterol With Evolocumab

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long-Term Coronary Events Following Myocardial Infarction or Unstable Angina: Results From the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study

The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study

Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study

Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

Aktive Filter

Suchergebnisse filtern